Story thread · 2 reports / 2 sources
Chasing Dupixent, a biotech aims to make better antibody drugs for eczema
biopharmadive.com · 11h · first report
Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications.
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.